Catch the Ask AI interview with Amit Deshwar, VP and Head of Predictive Systems at Deep Genomics, the AI Workbench used to prioritize transformational RNA therapeutics for genetic diseases.
<a href=" https://www.askai.org/post/e46-why-is-ai-essential-for-developing-new-medicines-for-genetic-diseases " target="_blank">Get all the links from our episode post</a>

Catch the Ask AI interview with Amit Deshwar, VP and Head of Predictive Systems at Deep Genomics, the AI Workbench used to prioritize transformational RNA therapeutics for genetic diseases. Get all the links from our episode post

Catch the Ask AI interview with Amit Deshwar, VP and Head of Predictive Systems at Deep Genomics, the AI Workbench used to prioritize transformational RNA therapeutics for genetic diseases.
<a href=" https://www.askai.org/post/e46-why-is-ai-essential-for-developing-new-medicines-for-genetic-diseases " rel="noopener noreferrer">Get all the links from our episode post</a>

E46 Interview: Why is AI essential for developing new medicines for genetic diseases?

Curious about AI and the future of work? The Ask AI podcast delivers thought-proviking interviews and practical insights that help you spot the opportunities and navigate the challenges associated with the increased use of artificial intelligence at work.

Episode Posts: https://www.askai.org/blog

Show Producer: https://www.linkedin.com/in/mclellanchris/

Business

Careers

Curious about AI and the future of work? The Ask AI podcast delivers thought-proviking interviews and practical insights that help you spot the opportunities and navigate the challenges associated with the increased use of artificial intelligence at work. Episode Posts: https://www.askai.org/blog Show Producer: https://www.linkedin.com/in/mclellanchris/

Share E46 Interview: Why is AI essential for developing new medicines for genetic diseases?

Sign up to save your podcasts

E46 Interview: Why is AI essential for developing new medicines for genetic diseases?

E46 Interview: Why is AI essential for developing new medicines for genetic diseases?